An experimental treatment reduces seizures and other symptoms in children with a type of epilepsy called Dravet syndrome.
Vasomune Therapeutics, Inc., ("Vasomune"), a clinical-stage biopharmaceutical company, today announced U.S. Food and Drug Administration (FDA) clearance of the Investigational New Drug (IND) ...
The anti-drug and substance abuse has raised alarm over the growing number of Kenyans in need of rehabilitation due to drug and substance addiction. This, the National Authority for the Campaign ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results